AnaptysBio
ANAB
ANAB
132 hedge funds and large institutions have $425M invested in AnaptysBio in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 31 increasing their positions, 51 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less funds holding in top 10
Funds holding in top 10: →
37% less capital invested
Capital invested by funds: $670M → $425M (-$245M)
39% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 51
98% less call options, than puts
Call options by funds: $25K | Put options by funds: $1.28M
Holders
132
Holding in Top 10
5
Calls
$25K
Puts
$1.28M
Top Buyers
| 1 | +$5.44M | |
| 2 | +$2.19M | |
| 3 | +$1.71M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.48M |
| 5 |
SG Americas Securities
New York
|
+$1.39M |
Top Sellers
| 1 | -$4.71M | |
| 2 | -$3.58M | |
| 3 | -$3.48M | |
| 4 |
O
OrbiMed
New York
|
-$2.88M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.82M |